Status:
UNKNOWN
Effect of Intranasal Insulin on POCD and POD
Lead Sponsor:
Hiroaki Sato, MD., PhD.
Conditions:
Delirium
Heart Diseases
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Decline in cognitive function after surgery occurs most commonly in older patients and patients undergoing major surgeries, such as heart surgery. Postoperative Cognitive Dysfunction (POCD) may last a...
Eligibility Criteria
Inclusion
- •elective open heart surgery requiring cardiopulmonary bypass
Exclusion
- inability to provide informed consent
- allergy to insulin
- pregnancy
- mother tongue other than English or French
- visual or hearing impairment interfering with the ability to complete cognitive tests.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
494 Patients enrolled
Trial Details
Trial ID
NCT03415061
Start Date
November 1 2021
End Date
November 30 2024
Last Update
October 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Victoria Hospital McGill University Health Centre
Montreal, Quebec, Canada, H4A3J1